Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 4Neoplasm Metastasis 3Colorectal Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Small Cell Lung Carcinoma 1Rhabdomyosarcoma 1Ovarian Neoplasms 1Microphthalmia, Isolated, with Coloboma 5 1Medulloblastoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Head and Neck Neoplasms 1Fanconi Anemia 1Desmoplastic Small Round Cell Tumor 1Carcinoma, Squamous Cell 1Breast Neoplasms 1Brain Neoplasms 1Anus Neoplasms 1Advanced Cancer 1

Interventions

fludarabine phosphate 4Antilymphocyte Serum 3fludarabine 2SRA737 2Peripheral Blood Stem Cell Transplantation 2Melphalan 2Cyclophosphamide 2Cord Blood Stem Cell Transplantation 2thymoglobulin 1sargramostim 1prexasertib 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Stem Cell Transplantation 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy 1Quercetin 1Polymerase Chain Reaction 1Mycophenolic Acid 1Microarray Analysis 1Methylprednisolone 1Immunoenzyme Techniques 1Gemcitabine 1Electrophoresis, Polyacrylamide Gel 1Dietary Supplements 1Clofarabine 1Cisplatin 1Chromatography, High Pressure Liquid 1Chromatography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Fanconi Anemia × prexasertib × Clear all
NCT02873975 2022-10-21

A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency

Dana-Farber Cancer Institute

Phase 2 Completed
27 enrolled 13 charts
Classical hematology

Fanconi Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡